Generic versions of dorzolamide-timolol (Cosopt) and dorzolamide hydrochloride (Trusopt; Merck) are now available from Prasco.
Generic versions of Merck's dorzolamide-timolol (Cosopt) and dorzolamide hydrochloride (Trusopt; Merck) are now being marketed in the US by Prasco Laboratories, under licence from Merck.
Prasco has released a statement detailing the therapeutic equivalence of its generic versions to Merck's branded drugs. As with the branded versions, the generic formulations are contained within the Ocumeter Plus dispensing container.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.